Golden Flower Yin Transition Formula

Margaritiferae Concha Usta (Mother of Pearl / Zhen Zhu Mu) 18%, Rehmanniae Radix (Rehmannia Root, unprocessed / Sheng Di Huang) 11%, Cortex Lycii (Lycium Root Bark, Chinese Wolfberry Rootbark / Di Gu Pi) 9%, Scrophulariae Radix (Scrophularia / Xuan Shen) 7%, Curculiginis Rhizoma (Curculigo Rhizome / Xian Mao) 7%, Ophiopogonis Radix (Ophiopogon Tuber / Mai Men Dong) 7%, Phellodendri Cortex (Phellodendron Bark / Huang Bai) 7%, Anemarrhenae Rhizoma (Anemarrhena Rhizome / Zhi Mu) 7%, Scutellariae Radix (Chinese Scullcap, Scutellaria, Scute / Huang Qin) 7%, Lycii Fructus (Lycium Fruit, Chinese Wolfberry / Gou Qi Zi) 6%, Schisandrae Fructus (Schisandra Fruit / Wu Wei Zi) 5%

Golden Flower Chinese Herbs (GFCH) was founded in 1990 by John Scott, DOM and Lorena Monda, DOM, with a goal to provide high quality, reasonably priced formulas without the impurities, adulterants or questionable ingredients found in other herbal products. All of the GFCH formulas are tested for pesticide residues, microbial activity and heavy metals and exceed current international GMP (Good Manufacturing Practice) standards. The GFCH product line has grown from five formulas in 1990 to over one hundred and thirteen in 2009, and includes formulas created by well-respected practitioners like Andrew Ellis and Jake Paul Fratkin.

GFCH offers optimally-concentrated formulations in tablet form, many of which are classical Chinese prescriptions and others of which are traditional preparations adapted to better serve the needs of modern Western patience or are new formulas based on traditional strategies to address modern complaints. Whether you choose a classical Chinese prescription or a new formula, you can be sure you are purchasing a product with uncompromising quality and purity. GFCH employs advanced techniques in herb selection, identification and processing to ensure the end result is a safe, correct and effective formula.